Cohort Studymoderate evidence
A Deep-Learning Based Biomarker of Systemic Cellular Senescence Burden to Predict Mortality and Health Outcomes.
Aging cell·October 1, 2026·PMID 42791602
Why it mattersA blood-based biomarker of senescence burden could help clinicians identify patients at elevated risk for age-related diseases and monitor responses to interventions aimed at reducing senescent cell accumulation.
The papers that matter, first.
MedLit ranks the medical literature into a specialty feed with concise summaries, evidence-aware triage, and visual takeaways.
§
MedLit · Evidence, Distilled